Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight loss with respect to energy expenditure, fat oxidation and calorie intake.
A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD. Medscape Medical News
GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a worrying new side-effect. Is it something to worry about or just a social media scare? We spoke with a doctor to find out
I congratulate Messiah et al on their publication entitled “Metabolic and Bariatric Surgery (MBS) Utilization in the Era of GLP-1 Receptor Agonists (GLP-1RA) among Adolescents Versus Adults.” The authors show an increase in adolescent MBS utilization from 2021-2023, which contrasts with adult data. This observation is interesting in the advent of second-generation GLP-1RAs (liraglutide and … Read more
We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock that gains or is expected to gain … Read more
What You Should Know: – PGxAI, a leader in AI-powered pharmacogenomics released a new report aimed at personalizing treatment regimens for patients taking semaglutide (commonly known by brand names Ozempic and Wegovy) and other widely used weight-management drugs. – Utilizing advanced artificial intelligence models, the report analyzes patient-specific genetic data to identify and quantify genetic … Read more
A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with interest in GLP-1 medications for weight loss. Conversely, body appreciation appears to protect against this interest, especially in the face of potential side effects.
Eli Lilly sues companies selling alternative versions of its weight loss drug : Shots – Health News NPR Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs WIRED Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro CNBC Lilly sues four compounders over copies of weight-loss drugs Reuters Eli Lilly opens a new legal front … Read more
Lilly sues four compounders over copies of weight-loss drugs Reuters Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs WIRED Eli Lilly sues companies selling alternative versions of its weight loss drug : Shots – Health News NPR Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro CNBC Eli Lilly opens a new legal front … Read more
